Details for New Drug Application (NDA): 022070

✉ Email this page to a colleague

NDA 022070 describes ATRALIN, which is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. Additional details are available on the ATRALIN profile page.

The generic ingredient in ATRALIN is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for 022070

Tradename:	ATRALIN
Applicant:	Dow Pharm
Ingredient:	tretinoin
Patents:	0

Pharmacology for NDA: 022070

Medical Subject Heading (MeSH) Categories for 022070

Antineoplastic Agents
Keratolytic Agents

Suppliers and Packaging for NDA: 022070

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ATRALIN	tretinoin	GEL;TOPICAL	022070	NDA	Bausch Health US, LLC	13548-070	13548-070-45	1 TUBE in 1 PACKAGE (13548-070-45) / 45 g in 1 TUBE
ATRALIN	tretinoin	GEL;TOPICAL	022070	NDA AUTHORIZED GENERIC	Obagi Cosmeceuticals LLC	62032-413	62032-413-20	20 g in 1 TUBE (62032-413-20)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	0.05%
Approval Date:	Jul 26, 2007	TE:	AB	RLD:	Yes

Expired US Patents for NDA 022070

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.